A non-isotopic neutravidin-based reverse transcriptase (RT) assay adapted for high throughput screening of HIV activity is described. Using a 96-well microtitre plate, HIV particles are lysed and the RT enzyme released into a reaction mixture containing poly(A) RNA, biotinylated oligo d
Introduction
Diagnostic assays that allow the detection of human immunodeficiency virus (HIV) are today an integral part of drug development, antiretroviral treatment monitoring, and patient management (Hirsch et al., 2000) . Currently, several methods are used for the routine analysis of HIV particles in patient plasma. Antigen capture enzyme-linked immunosorbent assay (ELISA) for quantification of the p24 gag protein of HIV-1 is commonly used for early diagnosis and to demonstrate virus replication (Lefrere et al., 1992) .
With the advent of HIV drug resistance testing for infected patients, recombinant DNA strategies were recently introduced which assess replication of resistant virus (Hertogs et al., 1998; Petropoulos et al., 2000) . The direct detection of HIV-associated reverse transcriptase (RT), however, is also often used as a simple, accurate and broadly applicable assay system for the measurement of HIV replication, particularly in the context of in vitro assays (Corrigan et al., 1998) .
The function of RT is to convert viral genomic RNA into a linear DNA duplex that is subsequently integrated into the viral genome (Tarrago-Litvak et al., 1994) . The expression of viral proteins (including protease) and production of progeny virions are essentially linked to this process. Radioactive strategies have been widely implemented to detect HIVassociated RT activity. In these assays, 3 H-or 32 P-labelled thymidine triphosphate is incorporated into DNA in the presence of poly(A) template and an oligo d(T) primer. Environmental and safety issues, however, have led to the development and use of non-radioactive detection systems (Deaver, 1995) . Nucleotides have been labelled with a variety of chemicals and the corresponding antibodies commercially produced for ELISA-based detection. Non-radioactive RT assays have been developed using various labels and detection systems (Ekstrand et al., 1996; Rytting et al., 1999) .
Here, we describe a simple non-radioactive ELISA system suitable for the high throughput screening of HIV-1 associated RT activity using fluorescein as a label and commercially available neutravidin-coated plates. The assay is as sensitive as the corresponding radioactive assay and has been successfully linked to an HIV-1 phenotyping assay to detect viral drug resistance and to assess fitness of HIV variants in infection cultures. We have focussed here on HIV-1 associated activity. However this assay may be applied to the detection of RT activity of other retroviruses. Plates were incubated at room temperature for 60 min. Wells were washed three times with 200 µl TBS containing 0.3% Tween-20. Antifluorescein antibody conjugated to alkaline phosphatase (NEN, Boston, USA) was diluted 1 : 500 in TBS/0.3% Tween and 50 µl was added to each well. After a further 60 min incubation, wells were washed three times with TBS/0.3% Tween and 200 µl pNPP substrate (Pierce, Rockford, USA) was added. Plates were incubated until yellow colour could be measured colorimetrically at wavelength 405 nm (Titertek Multiscan Plus MKII, Labsystems, UK) typically after an overnight incubation step.
Materials and Methods

Neutravidin-based RT assay
Radioactive RT assay The radioactive RT assay was performed as previously described (Klimkait et al., 1998) . In brief, the assay utilised 32 P-labelled dTTP (NEN) and oligo d(T) in a reaction mix that, after 2 h incubation at 37 o C was dot blotted onto DEAE paper. The paper was washed three times and exposed on autoradiography film.
DNA transfection HIV genes isolated from the peripheral blood of HIV patients were cloned into an infectious HIV vector as described (Brennan LE, 2000) . Approximately 0.2 µg cloned DNA was transfected into SX-22-1 HeLa cells (Klimkait et al., 1998) using Lipofectamine 2000 according to the protocol supplied by the manufacturer (Life Technologies, Basel, CH). Cells were subsequently incubated in fresh complete DMEM-medium, containing HIV inhibitor at the indicated concentration, for 48 h prior to collection of cells and viral supernatants. For immunoblot analysis, cells were scraped from the plates and lysed as previously described (Klimkait et al., 1998) .
Lymphocyte
infections Transfection supernatants were normalised for the number of viral particles present using transfection efficiency as a quantifiable marker (Klimkait et al., 1998) . For infection cultures, transfection supernatant was added to 1mL 8 × 10 4 CEM-SS cells in a 24-well plate. Infection supernatants were collected on days 4, 6, 8, 10, 12 and 15, centrifuged at 4000 rpm (Eppendorf tabletop centrifuge; Eppendorf, Hamburg, Germany) for 3 min prior to analysis by immunoblot or RT assay.
Results
Assay strategy In this assay, the reaction conditions optimised for HIV-associated RT activity was directly adapted from an established radioactive assay described above. Due to the availability of streptavidin-and more recently neutravidincoated 96 well plates, we utilised this platform to capture synthesised DNA and therefore used biotinylated oligo d(T) primers. Fluorescein-labelled nucleotide was chosen due to its inherent properties that may, in the future, allow direct detection methods. All other assay conditions were optimised for sensitivity as indicated in Materials and Methods.
Assay reproducibility and sensitivity The HIV-associated RT activity of supernatants obtained from lymphocytes chronically infected with HIV-1 was determined using the neutravidin-based assay described. As indicated in Figure 1B , a series of supernatants (1 × 10 6 HIV RNA copies per µL) diluted by 10-fold steps in culture media defined the lower limit of detectable activity. These data were reproducible and the variability within three independent assays was not significant (Mean absorbance values for the 10, 3, 1 and 0,1 µL volumes were 0.11, 0.04, 0.03 and 0.01, respectively. The corresponding standard deviations were 0.012, 0.014, 0.0092 and 0.006, respectively).
Sensitivity and limit of detection of the assay were compared to those of a corresponding radioactive assay (Fig. 1A) . Using both methods in parallel, we determined the RT activity in culture supernatants obtained as described above. Relative values and detection limits were consistently comparable between the two methods in three separate experiments.
Fig. 1.
Comparison of radioactive and neutravidin-based assays for HIV-associated RT activity. The indicated volumes of supernatant taken from HIV-1 infection cultures were analysed for HIV-associated RT activity using the radioactive assay (A) or the neutravidin-based non-radioactive assay (B). Intensity of radioactive signals was measured using a PhosphorImager and presented as PhosphorImager units. The neutravidin-based assay was analysed colorimetrically at wavelength 405 nm.
